In this case the described effects of NGF as a promoter of vascular-endothelial growth factor (VEGF) and neo-vascularization[159] gave the rationale background for treatment of a child with a severe crush syndrome of the lower left limb with subcutaneous mNGF. Here, VEGFA is linked to Crush Syndrome.